Free Trial

HEALTHCARE: Astra Zeneca (AZN: A2 pos / A+ / Au pos): Fitch Upgrade

HEALTHCARE
  • Last night Fitch upgraded AstraZeneca to A with Positive Outlook.  The rating is Unsolicited.
  • Fitch was too low vs Moody's and S&P given AZN's stunning performance.
  • EBITDA leverage expected to remain well below 2x in medium term.
  • Organic Revenue growth of high single digits expected through 2027 given late stage pipeline.

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.